News Endo gives way and withdraws opioid painkiller after FDA pre... Pharma makes decision after FDA intervenes to fight opioid crisis.
News As market declines, Purdue hopes to kick opiate habit Amid opiate crisis, Purdue looks for abuse-deterrent alternatives.
News Ipsen licenses Simcere ADC in $1bn-plus deal Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
